SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.7%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (16604)3/6/1998 3:16:00 PM
From: Henry Niman  Read Replies (4) of 32384
 
Do you know the publication date for Science? It would be nice to add that to March Madness. Last year the Nature publication on Targretin and Type II diabetes came out and it produced a nice price jump. It was coupled to the start of the European Phase II diabetes trial. However, LGND and Biotechs were heading south and the price jump was not sustained. This year however, LGND is on a roll. The price move from $11 to $16 has been impressive, but much more news is coming and LGND looks quite strong this month.

The implications for an oral version of GM-CSF are very strong and I would expect SBH to run with it. Merger mania is strong as are the big pharmas and a press release on the Science paper could really attract some interest.

The media is concentrating on the next blockbuster and an oral GM-CSF would really open some eyes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext